Sort
141,003 grants matching “cytokine”
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$1,252,261Robert Wiltrout · Basic Sciences · Z01 · FY2007 · CA
Mechanisms of New-Onset Autoimmunity/Longitudinal Immune Systems Analysis (MONA-LISA)
$1,252,131David R Karp · Ut Southwestern Medical Center · U01 · FY2025 · AI
Anti IL5 and Churg Strauss Syndrome: a double blind, placebo controlled trial
$1,251,988Michael E Wechsler · National Jewish Health · U01 · FY2016 · AI
Signaling in the retina and retinal pigment epithelium
$1,251,584Thomas Redmond · National Eye Institute · ZIA · FY2018 · EY
Clinical Research and Assay Support
$1,251,469Mary Walter · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2022 · DK
Cellular Decisions of Differentiation in the GI Tract
$1,251,176Juanita L Merchant · University Of Michigan At Ann Arbor · P01 · FY2008 · DK
Analysis and Characterization of Trauma-Induced Coagulopathy
$1,251,165Charles T Esmon · Oklahoma Medical Research Foundation · UM1 · FY2017 · HL
Novel Biologic Therapies for GVHD
$1,251,101Leslie S Kean · Boston Children'S Hospital · R01 · FY2021 · HL
Development of a novel adjuvant for vaccine sparing
$1,250,865Sara Lustigman · New York Blood Center · R01 · FY2016 · AI
Neuronal pathogenesis: acute and post-acute implications of viruses
$1,250,286Rahul Suryawanshi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Neuropathology and inflammation in a nonhuman primate model of insulin resistance/metabolic syndrome
$1,250,276Peter J Havel · University Of California At Davis · R01 · FY2025 · AG
Investigation of the intracellular and extracellular mechanisms underlying the process of aging
$1,250,120Yie Liu · National Institute On Aging · ZIA · FY2025 · AG
Stanford Technology Accelerating Medicines Partnership Center
$1,250,001William H Robinson · Stanford University · UH2 · FY2015 · AR
Clinical and Translational Science Award
$1,250,000Reza Shaker · Medical College Of Wisconsin · UL1 · FY2021 · TR
The Frontotemporal Lobar Degeneration Clinical Research Consortium
$1,250,000Adam L Boxer · University Of California, San Francisco · U54 · FY2018 · NS
Rare Diseases Clinical Research Consortia (RDCRC) for the RDCR Network
$1,250,000Mendel Tuchman · Children'S Research Institute · U54 · FY2015 · HD
The Frontotemporal Lobar Degeneration Clinical Research Consortium
$1,250,000Adam L Boxer · University Of California, San Francisco · U54 · FY2015 · NS
Rare Diseases Clinical Research Consortia (RDCRC) for the RDCR Network
$1,250,000Mark L Batshaw · Children'S Research Institute · U54 · FY2014 · HD
The Frontotemporal Lobar Degeneration Clinical Research Consortium
$1,250,000Adam L Boxer · University Of California, San Francisco · U54 · FY2014 · NS
Rare Diseases Clinical Research Consortia (RDCRC) for the RDCR Network
$1,250,000Andrea Lynne Gropman · Children'S Research Institute · U54 · FY2017 · HD
Rare Diseases Clinical Research Consortia (RDCRC) for the RDCR Network
$1,250,000Andrea Lynne Gropman · Children'S Research Institute · U54 · FY2016 · HD
The Frontotemporal Lobar Degeneration Clinical Research Consortium
$1,250,000Adam L Boxer · University Of California, San Francisco · U54 · FY2016 · NS
The Frontotemporal Lobar Degeneration Clinical Research Consortium
$1,250,000Adam L Boxer · University Of California, San Francisco · U54 · FY2017 · NS
AD04 disease-modifying drug for Alzheimer's - preclinical and IND-enabling studies
$1,249,957Carmela R Abraham · Advantage Therapeutics, Inc · R44 · FY2025 · AG
Autoimmune Drivers and Protectors Team Science (ADAPTS)
$1,249,430Judith A James · Oklahoma Medical Research Foundation · U01 · FY2025 · AI